ArticleTranslational vision science & technology2025
Photoreceptor Disease at Ambiguous Transition Zones in Inherited Retinal Degenerations.
Article in Translational vision science & technology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Clinical and Genetic Characteristics of a Chinese Occult Maculopathy Cohort.Translational vision science & technology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Purpose: Key outcome measures for inherited retinal degenerations (IRDs) are derived from the termination point of the inner and outer segment junction (IS/OS, or ellipsoid zone (EZ)) signal on optical coherence tomography (OCT), which demarcates the emergence of photoreceptor outer segment (OS) abnormalities. However, the termination point is not always abrupt and can be ambiguous. This study aimed to characterize OS disease at each retinal location. Methods: Widefield OCTs from two ABCA4-associated and fifteen RHO-associated IRD patients were recorded over ∼2 years. Data from a neighborhood of each sample were fed into a two-level artificial intelligence architecture, which achieved 95% accuracy for classifying outer retinal disease into definitely present OS (DPOS), definitely absent OS (DAOS), or questionably absent OS (QAOS). Results: DPOS and DAOS regions were always separated by QAOS regions; wider QAOS regions corresponded to an extended transition from OS disease to health. Point-by-point comparison of OS maps with serial widefield imaging showed that, on average, 94% of the samples remained stable, with the remainder showing progression. The best predictor of progression was the distance to the nearest locus with greater OS disease: DPOS and QAOS pixels within 2° and 5.5°, respectively, of a nearby location with greater disease had as much as 10-fold higher likelihood of progression. Conclusions: The assumption of an abrupt transition in EZ-based outcomes may not reflect the underlying pathophysiology of IRDs. Translational Relevance: Ambiguous transition zones and their immediate neighborhoods may demarcate retinal regions having high likelihood for progression and act as efficient endpoints for clinical trials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.